TY - JOUR
T1 - Association of two apolipoprotein A-I gene MspI polymorphisms with HDL-cholesterol levels and indices of obesity in selected healthy Chinese subjects and in patients with early onset Type 2 diabetes
AU - Ma, YQ
AU - Thomas, Graham
AU - Ng, MCY
AU - Critchley, JAJH
AU - Cockram, CS
AU - Chan, JCN
AU - Tomlinson, B
PY - 2003/10/1
Y1 - 2003/10/1
N2 - OBJECTIVE: Previous studies have reported associations between two apolipoprotein A-I (apoA-I) gene MspI polymorphisms (G-75A and C83T) and high density lipoprotein (HDL)-cholesterol and/or apoA-I levels, but have not investigated the relationship with obesity. METHODS: We determined the distribution of these polymorphisms in 482 early-onset (<or = 40 years) Type 2 Chinese diabetics and 167 Chinese selected healthy controls. RESULTS: The -75A and 83T allele frequencies were similar in the diabetic and healthy subjects. In the healthy control subjects, HDL-cholesterol levels were significantly higher in the AA homozygotes than in the GG/GA carriers (1.74 +/- 0.58 vs. 1.45 +/- 0.58 mmol/l, P
AB - OBJECTIVE: Previous studies have reported associations between two apolipoprotein A-I (apoA-I) gene MspI polymorphisms (G-75A and C83T) and high density lipoprotein (HDL)-cholesterol and/or apoA-I levels, but have not investigated the relationship with obesity. METHODS: We determined the distribution of these polymorphisms in 482 early-onset (<or = 40 years) Type 2 Chinese diabetics and 167 Chinese selected healthy controls. RESULTS: The -75A and 83T allele frequencies were similar in the diabetic and healthy subjects. In the healthy control subjects, HDL-cholesterol levels were significantly higher in the AA homozygotes than in the GG/GA carriers (1.74 +/- 0.58 vs. 1.45 +/- 0.58 mmol/l, P
U2 - 10.1046/j.1365-2265.2003.01865.x
DO - 10.1046/j.1365-2265.2003.01865.x
M3 - Article
C2 - 14510906
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
SN - 1365-2265
VL - 59
SP - 442
EP - 449
JO - Clinical Endocrinology
JF - Clinical Endocrinology
ER -